We just received data on a new analyst forecast for $CHD. Steve Powers from Deutsche Bank set a price target of 100.0 for CHD.
To track analyst ratings and price targets for $CHD, check out Quiver Quantitative's $CHD forecast page.
Should you buy $CHD?
Some analysts are better than others. To view the past performance of Deutsche Bank, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$CHD Price Targets
Multiple analysts have issued price targets for $CHD recently. We have seen 10 analysts offer price targets for $CHD in the last 6 months, with a median target of $100.0.
Here are some recent targets:
- Steve Powers from Deutsche Bank set a target price of $100.0 on 12/10/2025
- Taylor Conrad from Argus Research set a target price of $102.0 on 12/04/2025
- Lauren Lieberman from Barclays set a target price of $82.0 on 11/04/2025
- Rupesh Parikh from Oppenheimer set a target price of $100.0 on 10/21/2025
- Filippo Falorni from Citigroup set a target price of $85.0 on 10/09/2025
- Peter Grom from UBS set a target price of $98.0 on 10/08/2025
- Anna Lizzul from B of A Securities set a target price of $105.0 on 10/08/2025
$CHD Insider Trading Activity
$CHD insiders have traded $CHD stock on the open market 4 times in the past 6 months. Of those trades, 3 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CHD stock by insiders over the last 6 months:
- CARLEN HOOKER (EVP, Chief Commercial Officer) sold 6,380 shares for an estimated $627,161
- RICHARD A DIERKER (President and CEO) purchased 5,470 shares for an estimated $500,887
- LEE B MCCHESNEY (EVP, Chief Financial Officer) purchased 5,409 shares for an estimated $494,247
- MICHAEL READ (EVP, International) purchased 2,000 shares for an estimated $182,539
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CHD Revenue
$CHD had revenues of $1.6B in Q3 2025. This is an increase of 4.96% from the same period in the prior year.
You can track CHD financials on Quiver Quantitative's CHD stock page.
$CHD Congressional Stock Trading
Members of Congress have traded $CHD stock 5 times in the past 6 months. Of those trades, 2 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $CHD stock by members of Congress over the last 6 months:
- REPRESENTATIVE RICK W. ALLEN sold up to $50,000 on 10/10.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 4 times. They made 2 purchases worth up to $30,000 on 08/04, 06/17 and 2 sales worth up to $30,000 on 09/25, 06/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CHD Hedge Fund Activity
We have seen 402 institutional investors add shares of $CHD stock to their portfolio, and 644 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,705,492 shares (+56.5%) to their portfolio in Q3 2025, for an estimated $149,452,263
- CITADEL ADVISORS LLC removed 1,650,143 shares (-41.1%) from their portfolio in Q3 2025, for an estimated $144,602,031
- POINT72 ASSET MANAGEMENT, L.P. added 1,400,838 shares (+inf%) to their portfolio in Q3 2025, for an estimated $122,755,433
- CAPITAL RESEARCH GLOBAL INVESTORS removed 1,247,188 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $119,867,238
- ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. removed 937,617 shares (-91.8%) from their portfolio in Q3 2025, for an estimated $82,163,377
- CANDLESTICK CAPITAL MANAGEMENT LP added 861,651 shares (+inf%) to their portfolio in Q3 2025, for an estimated $75,506,477
- THRIVENT FINANCIAL FOR LUTHERANS added 835,618 shares (+3061.0%) to their portfolio in Q3 2025, for an estimated $73,225,205
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
